Page last updated: 2024-08-24

3-iodobenzylguanidine and Mood Disorders

3-iodobenzylguanidine has been researched along with Mood Disorders in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abe, S; Bokura, H; Kohno, N; Oguro, H; Toyoda, G; Yamaguchi, S1
Becker, G; Benecke, R; Braune, S; Büttner, T; Greulich, W; Klein, W; Mark, G; Müller, A; Rieke, J; Thümler, R1

Reviews

1 review(s) available for 3-iodobenzylguanidine and Mood Disorders

ArticleYear
Early diagnosis of Parkinson's disease.
    Journal of neurology, 2002, Volume: 249 Suppl 3

    Topics: 3-Iodobenzylguanidine; Affect; Biomarkers; Handwriting; Heart; Humans; Iron; Mood Disorders; Movement Disorders; Mutation; Olfaction Disorders; Parkinson Disease; Peripheral Nervous System Diseases; Psychomotor Performance; Radiopharmaceuticals; Risk Assessment; Risk Factors; Speech; Substantia Nigra; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ultrasonography; Vision, Ocular

2002

Other Studies

1 other study(ies) available for 3-iodobenzylguanidine and Mood Disorders

ArticleYear
Successful treatment of post-stroke apathy by the dopamine receptor agonist ropinirole.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2010, Volume: 17, Issue:6

    Topics: 3-Iodobenzylguanidine; Aged, 80 and over; Brain; Diffusion Magnetic Resonance Imaging; Dopamine Agonists; Humans; Indoles; Male; Mood Disorders; Radionuclide Imaging; Stroke

2010